UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the management of Helicobacter pylori infection and how to avoid them

Neil O´Morain, Anthony O'Connor

Summary

AI Generated

Helicobacter pylori, a Group 1 carcinogen affecting billions globally, shows declining infection rates in Europe with Dutch data demonstrating seroprevalence dropping from 48% to 16% across birth cohorts.

  • Helicobacter pylori infection is classified as a Group 1 carcinogen and its sequelae can lead to significant morbidity and mortality worldwide
  • Billions of people are currently infected with H. pylori globally
  • The incidence of H. pylori infection is declining in many parts of Europe
  • A Netherlands study showed seroprevalence declined from 48% in subjects born 1935-1946 to 16% in those born 1977-1987
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

The sequelae of Helicobacter pylori infection, a known Group 1 carcinogen, can lead to significant morbidity and mortality worldwide. Billions of people are infected with H. pylori, but the incidence of H. pylori infection is declining in many parts of Europe, with a study from the Netherlands showing a decline in seroprevalence from 48% in subjects born between 1935 and 1946 to 16% in those born between 1977 and 1987

Topics

Stomach & H. Pylori

Citation

O’Connor A and O’Moráin C. Mistakes in the management of Helicobacter pylori infection and how to avoid them. UEG Education 2017; 17: 42–44.

Published

2024

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in rumination syndrome and how to avoid them

Alberto Ezquerra-Durán, Elizabeth Barba Orozco

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

Topics

Neurogastroenterology & Motility

Citation

Ezquerra-Durán A and Barba-Orozco E. Mistakes in rumination syndrome and how to avoid them. UEG Education 2025; 25: 10-13.

Published

2025

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio, Giacomo Caio, Umberto Volta

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

Refractory coeliac disease (RCD) is characterized by the persistence or recurrence of symptoms and signs of malabsorption associated with villous atrophy in patients with coeliac disease who have adhered to a strict gluten-free diet (GFD) for more than 12 months.1–3 Serology is usually negative or, in a small percentage of cases, positive at a low titre.4 Splenic hypofunction, a risk factor for RCD, can be indicated by Howell–Jolly bodies and pitted red cells in a peripheral blood smear. A reduced spleen size visible on ultrasound examination also provides direct evidence of hyposplenism.5 

Topics

Small Intestine & Nutrition

Citation

Volta U, Caio G and De Giorgio R. Mistakes in refractory coeliac disease and how to avoid them. UEG Education 2019; 19: 15–18.

Published

2025

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo, Javier Molina-Infante

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

Eosinophilic oesophagitis (EoE) is a chronic immune-mediated inflammatory condition that is confined to the oesophagus. Clinically, EoE is characterized by symptoms of oesophageal dysfunction; histologically, by eosinophil-predominant inflammation.1,2 At present, EoE is the second-most frequent cause of chronic oesophagitis (gastro-oesophageal reflux disease [GORD] is the primary cause) and the foremost cause of dysphagia and food impaction in young adults and children.

Topics

Oesophagus

Citation

Molina-Infante J and Lucendo AJ. Mistakes in eosinophilic oesophagitis and how to avoid them. UEG Education 2017: 17; 6–9.

Published

2024

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord, Roos E. Pouw

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

Proton pump inhibitors (PPIs), first introduced with omeprazole in 1988, revolutionized the treatment of gastric acid-related conditions like gastro-oesophageal reflux disease, gastroduodenal ulcers, and Helicobacter pylori infections. Despite their effectiveness, PPIs are often prescribed for conditions without a proven link to gastric acid, such as dyspepsia and upper abdominal discomfort. Long-term use of PPIs has raised safety concerns, including risks of vitamin and mineral malabsorption, pneumonia, gastrointestinal infections, and dementia. This Mistakes In article addresses nine common mistakes in PPI use and aims to clarify misconceptions about their use.

Topics

Digestive Oncology Oesophagus

Citation

Pouw R.E. and Bredenoord A.J. Mistakes in the use of PPIs and how to avoid them. UEG Education 2017; 17: 15–17.

Published

2024

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

Around 11% of the worldwide population experience irritable bowel syndrome (IBS), making it one of the most frequent gastroenterological diagnoses.1 The symptoms of IBS include abdominal pain associated with unpredictable bowel habits and variable changes in the form and frequency of stool.2 While all patients with IBS suffer from recurrent bouts of abdominal pain, their bowel habits are varied: around one-third suffer predominantly with diarrhoea (IBS-D), one-fifth experience predominantly constipation (IBS-C) and half have an erratic mixed pattern of both diarrhoea and constipation (IBS-M).3 This very heterogeneous condition undoubtedly has multiple causes and an individualized approach to management and treatment is required. Here I discuss the mistakes most frequently made when diagnosing and managing IBS. The mistakes and discussion that follow are based, where possible, on published data and failing that on many years of my own clinical experience.

Topics

Neurogastroenterology & Motility Primary Care

Citation

Spiller R. Mistakes in irritable bowel syndrome and how to avoid them. UEG Education 2016: 16; 31–33.

Published

2024

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in microscopic colitis and how to avoid them

Andreas Münch

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10 Mistake 11
1.
van Blankenstein M, van Vuuren AJ, Looman CW, et al. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 2013; 48: 794–800. [Link]
2.
(#ref2)Malfertheiner P, Megraud F, Rokkas T et al; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8:gutjnl-2022-327745. [Link]
3.
Gisbert JP and Pajares JM. 13C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 2004; 20: 1001–1017. [Link]
4.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013; 12: CD008337. [Link]
5.
Molina-Infante J, Lucendo AJ, Angueira T, et al. Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. Aliment Pharmacol Ther 2015; 41: 581–589. [Link]
6.
O’Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117–127. [Link]
7.
Moayyedi P. Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000; 355: 1665–1669. [Link]
8.
Harvey RF, Lane JA, Murray LJ, et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project. BMJ 2004; 328: 1417–1420. [Link]
9.
Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 2010; 105: 1007–1013. [Link]
10.
Fitzmaurice C, Allen C, Barber R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 2017; 4: 524–548. [Link]
11.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 159: 2312–2316. [Link]
12.
Graham D, Lew G, Malaty H, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496. [Link]
13.
Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–60. [Link]
14.
O’Connor A, O’Moráin NR, Dobson M, et al. 182 Test, treat and retest. Who is best at checking for Helicobacter pylori eradication after a positive urea breath test (UBT), family physicians or gastroenterologists? Gastroenterology 2010; 138 (Suppl 1): S-33, DOI: 10.1016/S0016-5085(10)60153-9. [Link]
15.
Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34–42. [Link]
16.
Weston AP, Campbell DR, Hassanein RS, et al. Prospective, multivariate evaluation of CLOtest performance. Am J Gastroenterol 1997; 92: 1310–1315. [Link]
17.
Moon SW, Kim TH, Kim HS, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc 2012; 45: 392–396. [Link]
18.
Zou Y, Qian X, Liu X et al . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020;25(4):e12714.

Abstract

Microscopic colitis is an inflammatory bowel disease (IBD) that leads to chronic, watery diarrhoea. First believed to be rare, microscopic colitis has received more attention in recent decades, resulting in increasing incidence rates that exceed those of classic IBD in some countries. Hopefully, it is common practice nowadays to refer patients with chronic diarrhoea for a colonoscopy with biopsy samples taken, as this is the only way to diagnose microscopic colitis. Histology results distinguish between the subtypes of microscopic colitis — lymphocytic colitis, collagenous colitis and the more recently introduced incomplete microscopic colitis.


Topics

IBD

Citation

Münch A. Mistakes in microscopic colitis and how to avoid them. UEG Education 2021; 21: 10–13.

Published

2021

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Mistakes in refractory coeliac disease and how to avoid them

Mistakes in refractory coeliac disease and how to avoid them

Roberto De Giorgio Roberto De Giorgio, Giacomo Caio, Umberto Volta

Mistakes in eosinophilic oesophagitis and how to avoid them

Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo Alfredo J. Lucendo, Javier Molina-Infante

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in irritable bowel syndrome and how to avoid them

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller Robin Spiller

Mistakes in microscopic colitis and how to avoid them

Mistakes in microscopic colitis and how to avoid them

Andreas Münch Andreas Münch

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.